[1]
|
Arnold, M., Abnet, C.C., Neale, R.E., et al. (2020) Global Burden of 5 Major Types of Gastrointestinal Cancer. Gas-troenterology, 159, 335-349.e15 https://doi.org/10.1053/j.gastro.2020.02.068
|
[2]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[3]
|
Faiz, A.S., Khan, I., Beckman, M.G., Bockenstedt, P., Heit, J.A., Kulkarni, R., Manco-Johnson, M., Moll, S., Ortel, T.L. and Philipp, C.S. (2015) Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism. Thrombosis Research, 136, 535-541. https://doi.org/10.1016/j.thromres.2015.06.036
|
[4]
|
Levitan, N., et al. (1999) Rates of Initial and Recurrent Thromboembolic Disease among Patients with Malignancy versus Those without Malignancy: Risk Analysis Using Medicare Claims Data. Medicine, 78, 285-291.
https://doi.org/10.1097/00005792-199909000-00001
|
[5]
|
Couturaud, F., Mahé, I., Schmidt, J., Gleize, J.C., Lafon, T., Saighi, A., Sedjelmaci, F., Bertoletti, L. and Mismetti, P. (2023) Adult Breast, Lung, Pancreatic, Upper and Lower Gastrointestinal Cancer Patients with Hospitalized Venous Thromboembolism in the National French Hospital Discharge Database. BMC Cancer, 23, Article No. 531.
https://doi.org/10.1186/s12885-023-10877-4
|
[6]
|
Langer, F. and Bokemeyer, C. (2012) Crosstalk between Cancer and Haemostasis. Implications for Cancer Biology and Cancer-Associated Thrombosis with Focus on Tissue Factor. Hamostaseologie, 32, 95-104.
https://doi.org/10.5482/ha-1160
|
[7]
|
王昊, 袁建松. 消化道恶性肿瘤并发静脉血栓栓塞的分子机制与风险评估[J]. 中国分子心脏病学杂志, 2021, 21(6): 4380-4383.
|
[8]
|
Khorana, A.A., Mackman, N., Falanga, A., Pabinger, I., Noble, S., Ageno, W., Moik, F. and Lee, A.Y.Y. (2022) Cancer-Associated Venous Thromboembolism. Nature Reviews Disease Primers, 8, Article No. 11.
https://doi.org/10.1038/s41572-022-00336-y
|
[9]
|
Falanga, A., Brenner, B., Khorana, A.A. and Francis, C.W. (2022) Thrombotic Complications in Patients with Cancer: Advances in Pathogenesis, Prevention, and Treatment—A Report from ICTHIC 2021. Research and Practice in Thrombosis and Haemostasis, 6, E12744. https://doi.org/10.1002/rth2.12744
|
[10]
|
Tawil, N., Bassawon, R. and Rak, J. (2019) Oncogenes and Clotting Factors: The Emerging Role of Tumor Cell Genome and Epigenome in Cancer-Associated Thrombosis. Seminars in Thrombosis and Hemostasis, 45, 373-384.
https://doi.org/10.1055/s-0039-1687891
|
[11]
|
王辉. 消化系统恶性肿瘤并发静脉血栓栓塞症危险因素分析[D]: [硕士学位论文]. 长春: 吉林大学, 2020.
|
[12]
|
Osborne, N.H., Wakefield, T.W. and Henke, P.K. (2008) Venous Thromboembolism in Cancer Patients Undergoing Major Surgery. Annals of Surgical Oncology, 15, 3567-3578. https://doi.org/10.1245/s10434-008-0151-4
|
[13]
|
宋传法. 外周血液呈高凝状态与胃癌临床特征的相关性研究[D]: [硕士学位论文]. 西宁: 青海大学, 2023.
|
[14]
|
Prandoni, P., Falanga, A. and Piccioli, A. (2005) Cancer and Ve-nous Thromboem-Bolism. The Lancet Oncology, 6, 401-410. https://doi.org/10.1016/S1470-2045(05)70207-2
|
[15]
|
Connors, J.M. (2014) Prophylaxis against Venous Throm-boembolism in Ambu-Latory Patients with Cancer. The New England Journal of Medicine, 370, 2515-2519. https://doi.org/10.1056/NEJMra1401468
|
[16]
|
Elyamany, G., Alzahrani, A.M. and Bukhary, E. (2014) Can-cer-Associated Thrombosis: An Overview. Clinical Medicine Insights: Oncology, 8, 129-137. https://doi.org/10.4137/CMO.S18991
|
[17]
|
White, R.H., Zhou, H., Murin, S. and Harvey, D. (2005) Effect of Ethnicity and Gender on the Incidence of Venous Thromboembolism in a Diverse Population in California in 1996. Thrombosis and Haemostasis, 93, 298-305.
https://doi.org/10.1160/TH04-08-0506
|
[18]
|
Mahajan, A., Brunson, A., White, R., et al. (2019) The Epidemiology of Cancer -Associated Venous Thromboembolism: An Update. Seminars in Thrombosis and Hemostasis, 45, 321-325. https://doi.org/10.1055/s-0039-1688494
|
[19]
|
Walker, A.J., Card, T.R., West, J., et al. (2013) Incidence of Venous Thromboembolism in Patients with Cancer—A Cohort Study Using Linked United Kingdom Databases. European Journal of Cancer, 49, 1404-1413.
https://doi.org/10.1016/j.ejca.2012.10.021
|
[20]
|
Zayed, M.A., De Silva, G.S., Ramaswamy, R.S., et al. (2017) Management of Cavoatrial Deep Venous Thrombosis: Incorporating New Strategies. Seminars in Interventional Radi-ology, 34, 25-34.
https://doi.org/10.1055/s-0036-1597761
|
[21]
|
本刊编辑部. 《中国肿瘤临床》文章推荐:肿瘤相关静脉血栓栓塞症预防与治疗指南(2019版) [J]. 中国肿瘤临床, 2019(23): 1198.
|
[22]
|
Khorana, A.A., Francis, C.W., Culakova, E., et al. (2007) Frequency, Risk Factors, and Trends for Venous Thromboembolism among Hospitalized Cancer Patients. Cancer, 110, 2339-2346. https://doi.org/10.1002/cncr.23062
|
[23]
|
Chew, H.K., Wun, T., Harvey, D., et al. (2006) Incidence of Venous Thromboembolism and Its Effect on Survival among Patients with Common Cancers. Arch Internal Medicine, 166, 458-464.
https://doi.org/10.1001/archinte.166.4.458
|
[24]
|
白阳, 陈虹. 恶性肿瘤相关静脉血栓栓塞症的预防和治疗[J]. 国际呼吸杂志, 2020, 40(1): 5-10.
|
[25]
|
Hisada, Y. and Mackman, N. (2017) Cancer-Associated Pathways, and Bi-omarkers of Venous Thrombosis. Blood, 130, 1499-1506. https://doi.org/10.1182/blood-2017-03-743211
|
[26]
|
Vormittag, R., Simanek, R., Ay, C., et al. (2009) High Factor VIII Levels Independently Predict Venous Thromboembolism in Cancer Patients: The Cancer and Thrombosis Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 29, 2176-2181. https://doi.org/10.1161/ATVBAHA.109.190827
|
[27]
|
Horsted, F., West, J. and Grainge, M.J. (2012) Risk of Ve-nous Thromboembolism Inpatients with Cancer: A Systematic Review and Meta-Analysis. PLOS Medicine, 9, e1001275. https://doi.org/10.1371/journal.pmed.1001275
|
[28]
|
刘宗超, 李哲轩, 张阳, 周彤, 张婧莹, 游伟程, 潘凯枫, 李文庆. 2020全球癌症统计报告解读[J]. 肿瘤综合治疗电子杂志, 2021, 7(2): 1-13.
|
[29]
|
Shah, M.A., Capanu, M., Soff, G., Asmis, T. and Kelsen, D.P. (2010) Risk Factors for Developing a New Venous Thromboembolism in Ambulatory Patients with Non-Hematologic Malignancies and Impact on Survival for Gastroesophageal Malignancies. Journal of Thrombosis and Haemostasis, 8, 1702-1709.
https://doi.org/10.1111/j.1538-7836.2010.03948.x
|
[30]
|
Martin, L.K. and Bekaii-Saab, T. (2012) Management of Venous Thromboembolism in Patients with Advanced Gastrointestinal Cancers: What Is the Role of Novel Oral Anti-coagulants? Thrombosis, 2012, Article ID: 758385.
https://doi.org/10.1155/2012/758385
|
[31]
|
Frere, C., Bournet, B., Gourgou, S., Fraisse, J., Canivet, C., Connors, J.M., Buscail, L., Farge, D. and BACAP Consortium (2020) Incidence of Venous Thromboembolism in Patients with Newly Diagnosed Pancreatic Cancer and Factors Associated with Outcomes. Gastroenterology, 158, 1346-1358.E4.
|
[32]
|
Campello, E., Ilich, A., Simioni, P. and Key, N.S. (2019) The Relationship between Pancreatic Cancer and Hypercoagulability: A Comprehensive Review on Epidemiological and Biological Issues. British Journal of Cancer, 121, 359-371.
https://doi.org/10.1038/s41416-019-0510-x
|
[33]
|
马军, 秦叔逵, 吴一龙, 李进, 朱军, 季加孚, 石远凯. 肿瘤相关静脉血栓栓塞症预防与治疗指南(2019版) [J]. 中国肿瘤临床, 2019, 46(13): 653-660.
|
[34]
|
Li, X.P., Wang, Y.Y., Sun, Y.S., Zhang, L.J., Zhao, X.Y., Liu, Z.Q., Jiang, H.M., Zha, J.D., Zhang, X.J., Yan, J.N. and Pan, H.Y. (2022) Preoperative and Postoperative Clinical Signatures of Postgastrectomy Venous Thromboembolism (VTE) in Patients with Gastric Cancer: A Retrospective Cohort Study. Asian Journal of Surgery, 46, 1556-1563.
|
[35]
|
Bosch, D.J., Van Dalfsen, Q.A., Mul, V.E.M., Hospers, G.A.P. and Plukker, J.T.M. (2014) Increased Risk of Thromboembolism in Esophageal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy. The American Journal of Surgery, 208, 215-221. https://doi.org/10.1016/j.amjsurg.2013.10.031
|
[36]
|
Jatoi, A., Soori, G., Foster, N.R., Hiatt, B.K., Knost, J.A., Fitch, T.R., et al. (2010) Phase II Study of Preoperative Pemetrexed, Carboplatin, and Radiation Followed by Surgery for Locally Advanced Esophageal Cancer and Gastroesophageal Junction Tumors. Journal of Thoracic On-cology, 5, 1994-1998.
https://doi.org/10.1097/JTO.0b013e3181fb5c3e
|
[37]
|
Kato, F., Takeuchi, H., Matsuda, S., Kawakubo, H., Omori, T. and Kitagawa, Y. (2016) Incidence of and Risk Factors for Venous Thromboembolism During Surgical Treatment for Esophageal Cancer: A Single-Institution Study. Surgery Today, 46, 445-452. https://doi.org/10.1007/s00595-015-1196-1
|
[38]
|
Verhage, R.J.J., Van Der Horst, S., Van Der Sluis, P.C., Lolkema, M.P.J.K. and Van Hillegersberg, R. (2012) Risk of Thromboembolic Events after Perioperative Chemotherapy versus Surgery Alone for Esophageal Adenocarcinoma. Annals of Surgical Oncology, 19, 684-692. https://doi.org/10.1245/s10434-011-2005-8
|
[39]
|
Cassidy, M.R., Rosenkranz, P. and McAneny, D. (2014) Reducing Post-Operative Venous Thromboembolism Complications with a Standardized Risk-Stratified Prophylaxis Protocol and Mobi-Lization Program. Journal of the American College of Surgeons, 218, 1095-1104. https://doi.org/10.1016/j.jamcollsurg.2013.12.061
|
[40]
|
Samama, C.M., Boubli, L., Coloby, P., et al. (2014) Venous Thrombo-Embolism Prophylaxis in Patients Undergoing Abdominal or Pelvic Surgery for Cancer—A Real-World, Prospective, Obser-Vational French Study: PReOBS. Thrombosis Research, 133, 985-992. https://doi.org/10.1016/j.thromres.2013.10.038
|
[41]
|
De Martino, R.R., Goodney, P.P., Spangler, E.L., Wallaert, J.B., Corriere, M.A., Rzucidlo, E.M., Walsh, D.B. and Stone, D.H. (2012) Variation in Thromboembolic Complications among Patients Undergoing Commonly Performed Cancer Operations. Journal of Vascular Surgery, 55, 1035-1040.E4. https://doi.org/10.1016/j.jvs.2011.10.129
|
[42]
|
Mulder, F.I., Hovenkamp, A., Van Laarhoven, H.W.M., Büller, H.R., Kamphuisen, P.W., Hulshof, M.C.C.M., Van Berge Henegouwen, M.I., Middeldorp, S. and Van Es, N. (2020) Thromboembolic and Bleeding Complications in Patients with Oesophageal Cancer. British Journal of Surgery, 107, 1324-1333. https://doi.org/10.1002/bjs.11665
|
[43]
|
Seto, S., Onodera, H., Kaido, T., Yoshikawa, A., Ishigami, S., Arii, S. and Imamura, M. (2000) Tissue Factor Expression in Human Colorectal Carcinoma: Correlation with Hepatic Metastasis and Impact on Prognosis. Cancer, 88, 295-301.
https://doi.org/10.1002/(SICI)1097-0142(20000115)88:2<295::AID-CNCR8>3.0.CO;2-U
|
[44]
|
王磊, 颜登国. 老年结直肠癌病人围手术期手术危险因素分析[J]. 临床外科杂志, 2019, 27(11): 999-1001.
|
[45]
|
Gould, M.K., Garcia, D.A., Wren, S.M., et al. (2012) Prevention of VTE in Nonorthopedic Surgical Patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, 1369. https://doi.org/10.1378/chest.141.5.1369b
|
[46]
|
Fleming, F.J., Kim, M.J., Salloum, R.M., et al. (2010) How Much Do We Need to Worry about Venous Thromboembolism after Hospital Discharge? A Study of Colorectal Surgery Patients Using the National Surgical Quality Improvement Program Database. Diseases of the Colon & Rectum, 53, 1355-1360.
https://doi.org/10.1007/DCR.0b013e3181eb9b0e
|
[47]
|
Agnelli, G., Bolis, G., Capussotti, L., et al. (2006) A Clinical Outcome-Based Prospective Study on Venous Thromboembolism after Cancer Surgery: The @RISTOS Project. Annals of Surgery, 243, 89-95.
https://doi.org/10.1097/01.sla.0000193959.44677.48
|
[48]
|
Liu, F.L. and Zhang, T.P. (2016) Chinese Guidelines for Prevention and Management of Perioperative Thrombosis in General Surgery. Chinese Journal of Practical Surgery, 36, 469-474.
|
[49]
|
Douketis, J.D., Spyropoulos, A.C., Spencer, F.A., et al. (2012) Perioperative Management of Antithrombotic Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, 1129. https://doi.org/10.1378/chest.141.4.1129b
|
[50]
|
Bang, S.M., Jang, M.J., Kim, K.H., et al. (2014) Prevention of Venous Thromboembolism, 2nd Edition: Korean Society of Thrombosis and Hemostasis Evidence-Based Clinical Practice Guidelines. Journal of Korean Medical Science, 29, 164-171. https://doi.org/10.3346/jkms.2014.29.2.164
|
[51]
|
Bahl, V., Hu, H.M., Henke, P.K., et al. (2010) A Validation Study of a Retrospective Venous Thromboembolism Risk Scoring Method. Annals of Surgery, 251, 344-350. https://doi.org/10.1097/SLA.0b013e3181b7fca6
|
[52]
|
Zhou, H., Wang, L., Wu, X., et al. (2014) Validation of a Venous Thromboembolism Risk Assessment Model in Hospitalized Chinese Patients: A Case-Control Study. Journal of Atherosclerosis and Thrombosis, 21, 261-272.
https://doi.org/10.5551/jat.20891
|
[53]
|
Liu, X., Liu, C., Chen, X., et al. (2016) Comparison between Caprini and Padua Risk Assessment Models for Hospitalized Medical Patients at Risk for Venous Thromboembolism: A Retro-spective Study. Interactive CardioVascular and Thoracic Surgery, 23, 538-543. https://doi.org/10.1093/icvts/ivw158
|
[54]
|
Fleming, F., Gaertner, W., Ternent, C.A., et al. (2018) The American Society of Colon and Rectal Surgeons Clinical Practice Guideline for the Prevention of Venous Thromboembolic Disease in Colorectal Surgery. Diseases of the Colon & Rectum, 61, 14-20. https://doi.org/10.1097/DCR.0000000000000982
|
[55]
|
Rasmussen, M.S., Jørgensen, L.N. and Wille-Jørgensen, P. (2009) Prolonged Thromboprophylaxis with Low Molecular Weight Heparin for Abdominal or Pelvic Surgery. Cochrane Database of Systematic Reviews, 1, CD004318.
https://doi.org/10.1002/14651858.CD004318.pub2
|
[56]
|
Attar, B.M. and Van Thiel, D.H. (2013) Current Concepts and Management Approaches in Nonalcoholic Fatty Liver Disease. The Scientific World Journal, 2013, Article ID: 481893. https://doi.org/10.1155/2013/481893
|
[57]
|
Wang, Y., Attar, B.M., Hinami, K., Fuentes, H.E., Jaiswal, P., Zhang, H., Simons-Linares, C.S. and Tafur, A.J. (2018) Characteristics and Impacts of Venous Thromboembolism in Patients with Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer, 49, 275-282. https://doi.org/10.1007/s12029-017-9945-6
|
[58]
|
Fuentes, H.E., Tafur, A. and Caprini, J.A. (2016) Can-cer-Associated Thrombosis. Disease-a-Month, 62, 121-158.
https://doi.org/10.1016/j.disamonth.2016.03.003
|